World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
14850
World Ranking
2768
National Ranking
104

J.H. Frederik Falkenburg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where J.H. Frederik Falkenburg sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 369 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

J.H. Frederik Falkenburg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where J.H. Frederik Falkenburg sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

J.H. Frederik Falkenburg is affiliated with Leiden University Medical Center in the Netherlands and conducts research primarily in the fields of Immunology and Microbiology as well as Medicine. Their scientific work encompasses a range of topics related to immune system function and therapeutic interventions.

The main areas of study in Falkenburg's research include:

  • Immunology and Microbiology
  • Medicine

Falkenburg's research covers subfields such as Immunology, Oncology, Hematology, Molecular Biology, and Genetics. The specific scientific topics addressed in their work are diverse and focus largely on immune system interactions, therapeutic strategies, and disease mechanisms. These include:

  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Hematopoietic Stem Cell Transplantation
  • Vaccines and immunoinformatics approaches
  • Virus-based gene therapy research

Among the recent papers authored by Falkenburg are notable studies including:

  • Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM, published in 2020 in Blood
  • Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure, published in 2022 in OncoImmunology
  • HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study, published in 2020 in Frontiers in Immunology
  • Immunopeptidome Analysis of HLA-DPB1 Allelic Variants Reveals New Functional Hierarchies, published in 2020 in The Journal of Immunology
  • Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals, published in 2022 in Frontiers in Immunology

Falkenburg frequently publishes in various scientific journals, including:

  • Frontiers in Immunology
  • Blood
  • Journal for ImmunoTherapy of Cancer
  • The Journal of Immunology
  • Molecular Therapy - Oncolytics

The scientist has collaborated extensively with a number of frequent co-authors such as Mirjam H.M. Heemskerk, Dennis F.G. Remst, Michel G.D. Kester, Anne K. Wouters, and Renate S. Hagedoorn, illustrating a collaborative research network focused on immunological and hematological studies.

Best Publications

  • Mesenchymal stem cells promote engraftment of human umbilical cord blood–derived CD34+ cells in NOD/SCID mice

    Willy A Noort;Alwine B Kruisselbrink;Pieternella S in't Anker;Marjolein Kruger

  • Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia.

    W. A. Erik Marijt;Mirjam H. M. Heemskerk;Freke M. Kloosterboer;Els Goulmy

  • Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells

    A. A. A. M. Danen-Van Oorschot;D. F. Fischer;J. M. Grimbergen;B. Klein

  • Allo-HLA reactivity of virus-specific memory T cells is common.

    Avital L. Amir;Lloyd J. A. D'Orsogna;Dave L. Roelen;Marleen M. van Loenen

  • Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes.

    J.H. Frederik Falkenburg;Amon R. Wafelman;Peter Joosten;Willem M. Smit

  • Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region.

    Mirjam H M Heemskerk;Manja Hoogeboom;Roelof A de Paus;Michel G D Kester

  • Mixed T cell receptor dimers harbor potentially harmful neoreactivity

    Marleen M. van Loenen;Renate de Boer;Avital L. Amir;Renate S. Hagedoorn

  • Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer.

    Mirjam H.M. Heemskerk;Manja Hoogeboom;Renate S. Hagedoorn;Michel G.D. Kester

  • Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex

    Mirjam H. M. Heemskerk;Renate S. Hagedoorn;Menno A. W. G. van der Hoorn;Lars T. van der Veken

  • Hematopoietic SCT in Europe 2013: Recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

    J R Passweg;H Baldomero;P Bader;C Bonini

  • New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population

    Inge Jedema;Nicole M. van der Werff;Renée M. Y. Barge;Roel Willemze

  • PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.

    Wieger J. Norde;Frans Maas;Willemijn Hobo;Alan Korman

  • UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition.

    Mario H. J. Vogt;Els Goulmy;Freke M. Kloosterboer;Els Blokland

  • Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia.

    Dyantha I. van der Lee;Rogier M. Reijmers;Maria W. Honders;Renate S. Hagedoorn

  • Minor histocompatibility antigens in human stem cell transplantation

    J.H.Frederik Falkenburg;Lisette van de Corput;Erik W.A Marijt;Roel Willemze

  • The DBY gene codes for an HLA-DQ5 restricted human male-specific minor histocompatibility antigen involved in graft versus host disease.

    Mario H. J. Vogt;Joost W. van den Muijsenberg;Els Goulmy;Eric Spierings

  • Hematopoietic SCT in Europe: data and trends in 2011

    J R Passweg;H Baldomero;M Bregni;S Cesaro

  • Human fibroblasts produce granulocyte-CSF, macrophage-CSF, and granulocyte-macrophage-CSF following stimulation by interleukin-1 and poly(rI).poly(rC).

    WE Fibbe;J Van Damme;A Billiau;N Duinkerken

  • Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy

    Marieke Griffioen;Esther H.M. van Egmond;Michel G.D. Kester;Roel Willemze

  • NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.

    David L. Porter;Edwin P. Alyea;Joseph H. Antin;Marcos DeLima

  • Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy

    Anniek B. van der Waart;Noortje M. P. van de Weem;Frans Maas;Cynthia S. M. Kramer

  • αβ T-Cell Receptor Engineered γδ T Cells Mediate Effective Antileukemic Reactivity

    Lars T. van der Veken;Renate S. Hagedoorn;Marleen M. van Loenen;Roel Willemze

Frequent Co-Authors

Mirjam H.M. Heemskerk
Mirjam H.M. Heemskerk Leiden University Medical Center
Roel Willemze
Roel Willemze Leiden University Medical Center
Peter A. van Veelen
Peter A. van Veelen Leiden University Medical Center
Harry Dolstra
Harry Dolstra Radboud University
Willem E. Fibbe
Willem E. Fibbe Leiden University Medical Center
Henk-Jan Guchelaar
Henk-Jan Guchelaar Leiden University Medical Center
Jan W. Drijfhout
Jan W. Drijfhout Leiden University Medical Center
Joop H. Jansen
Joop H. Jansen Radboud University
Els Goulmy
Els Goulmy Leiden University Medical Center
Jaap T. van Dissel
Jaap T. van Dissel Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, numerous related online degree programs offer rewarding career opportunities. Many professionals in healthcare pursue specialized paths such as psychiatric nursing by enrolling in the cheapest online pmhnp certificate programs. These programs provide affordable options to gain critical skills in mental health care.

Advancing education to a Doctorate in Nursing Practice (DNP) can lead to enhanced salary prospects. If you're curious about regional differences, the doctorate in nursing salary data offers valuable insights into earning potential across various states in the USA.

Transitioning from Family Nurse Practitioner (FNP) roles to more specialized areas, like acute care, is possible through targeted programs. Exploring acute care nurse practitioner programs can help streamline this career shift with relevant skills and training.

Additionally, for registered nurses eager to advance quickly, accelerated rn to np programs are designed to fast-track the journey to becoming a Nurse Practitioner, balancing speed with comprehensive education.

Best Scientists Citing J.H. Frederik Falkenburg

Trending Scientists

Recently Published Articles